Sorry I had a very busy day. I am not sure I have too much more to add beyond what has been posted out across a half dozen posts. I guess the TLDR is the results are excellent, the market is extremely short sighted, and there is a lot to look forward to over the months ahead as ILA lays out its plans.
David and Phil have been spending a lot of time in Asia where the market understands how serious Dengue is and the commercial opportunity ISLA-101 offers. Us shareholders should be worried that if we collectively keep acting like total tards that ILA will be stolen from us.
Ann: Successful Phase 2 clinical trial of ISLA-101, page-51
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.010(6.25%) |
Mkt cap ! $37.08M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 14.5¢ | $99.96K | 664.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 206896 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 18900 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| ILA (ASX) Chart |